News

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
‘People inside Moderna are afraid’: As the anti-vaccine climate intensifies, a big local firm has much to lose
Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...
Moderna Seeks Outside Investors to Fund Select Vaccine Trials
Moderna Inc. is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as ...
FDA OKs new Moderna COVID-19 vaccine for 65+, others with conditions
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
How Moderna Went From Pandemic Hero to Vaccine Victim
The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...
Rheumatology Advisor1d
FDA Approves Moderna’s Next-Generation COVID-19 Vaccine mNexspike
The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.
Healio9d
FDA approves Moderna’s lower-dose COVID-19 vaccine for some
The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to ...
Renal & Urology News1d
Moderna’s New Lower-Dose COVID-19 Vaccine Approved by FDA
(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.
FDA approves Moderna's new lower-dose COVID-19 vaccine
The FDA’s approval was based on a study of 11,400 people ages 12 and older that compared the new low-dose vaccine with ...